Skip to main content
Equibles

Craig A. Wheeler

Board Member

Apellis Pharmaceuticals, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Craig A. Wheeler

Craig A. Wheeler is recorded as Board Member at Apellis Pharmaceuticals, Inc.. Apellis Pharmaceuticals, Inc. reported in an 8-K filed May 14, 2026 that Craig A. Wheeler resigned as member of the Board of Directors of the Company and any committee thereof, effective May 14, 2026. Apellis Pharmaceuticals, Inc. reported in an 8-K filed April 21, 2025 that Craig A. Wheeler was appointed Class III director, effective April 17, 2025.

“Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.”
Apellis Pharmaceuticals, Inc. Form 8-K, filed May 14, 2026 · Read the filing
“On April 17, 2025, the Board of Directors (the "Board") of Apellis Pharmaceuticals, Inc. (the "Company"), upon recommendation from the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), elected Craig A. Wheeler to the Board as a Class III director to serve until the Annual Meeting of Stockholders to be held in 2026 or until his successor has been duly elected and qualified or until his earlier death, resignation or removal.”
Apellis Pharmaceuticals, Inc. Form 8-K, filed April 21, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Apellis Pharmaceuticals, Inc.

    Board Member

    SEC 8-K

    Current

    2025-04-17–present

  • Apellis Pharmaceuticals, Inc.

    Board Member

    SEC 8-K

    2025-04-17–2026-05-14

Company network

Recorded roles and call appearances connecting this person to public companies.

Apellis Pharmaceuticals, Inc.

Current role

Board Member

2025-04-17–present

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.